Today's Spotlight

A Peek at the Pinhole

A patient may present to your office with reduced vision for any number of reasons, ranging from something as benign as uncorrected refractive error to serious pathology. Even in cases in which a combination of factors affect vision, the ability to distinguish between contributory ocular pathology and a refractive error is a must. Despite today’s high-tech tools—such as autorefractors or the potential acuity meter (PAM), to name a few—many ODs turn to a tried-and-true low-tech option: the pinhole occluder. 

Today's Spotlight

Spring—and Pollen—is in the Air

The foundation for each and every professional encounter begins with the case history; from a coding perspective, it is the most integral portion of your encounter.

Today's Spotlight

Steroid Wars: New Drugs Challenge Old Habits

Adverse reactions from steroid use include, but are not limited to, cataract formation, increased intraocular pressure (IOP), possible secondary infections, delayed wound healing and even central serous retinopathy (CSR). Although these events can be serious and are worth considering, the benefits of steroids often outweigh their risks. 

Today's Spotlight

Modifying Your Glaucoma Regimen: When, Why and How

As optometrists, we are well positioned to diagnose and treat glaucoma; however, it’s not as simple as identifying someone with elevated intraocular pressure (IOP) and then lowering it as much as possible. One report calculated more than 56,000 ways to treat glaucoma after taking into account all available medications and possible regimens ranging from monotherapy to maximum medical therapy. Although glaucoma care remains more of an art than an exact science, a structured approach allows us to initiate—and tweak—treatment plans for each individual. 

Today's Spotlight

How—and Why—to Choose Dry Eye Drugs

For patients with dry eye disease (DED), treatment options were once confined to artificial tears, warm compresses and the occasional off-label steroid. While some of these help soothe symptoms, they do little to truly manage the disease, especially as it worsens. For patients no longer treatable with these at-home remedies, new research shows a cascade of discoveries in both diagnosis and treatment.

Mar 28
Mar 27
Mar 26
Mar 25
Mar 24

The News Feed

Look Inside The Current Issue

March 15, 2020

Features

Four Steps to Make Premium IOLs Worth the Cost

Cataract patients have high demands. Here’s how clinicians can use today’s technologies and techniques to meet them.

How—and Why—to Choose Dry Eye Drugs

Properly pairing a patient with a pharmaceutical requires an understanding of the individual’s underlying condition and overall health.

Modifying Your Glaucoma Regimen: When, Why and How

Managing this disease requires careful consideration of myriad factors. Here’s how you can structure your approach.

Steroid Wars: New Drugs Challenge Old Habits

Here’s how novel delivery systems and updated formulations may one day overcome the current challenges inherent in topical steroid prescribing.

The Do's & Don'ts of Oral Medication

Understanding when and how to prescribe oral medications will help optometrists provide optimal patient care.

What OCT Can Offer Your Specialty Lens Fits

This technology is especially useful for customizing the design and troubleshooting any associated conditions.

Departments

Chew on This

A dental abscess may be the cause of a patient’s preseptal or orbital cellulitis.

A Peek at the Pinhole

This simple test can quickly categorize a patient’s reduced vision as either refractive or pathological. Here’s what else it can do.

Don’t Blame Pharma

Industry bears the brunt of the public’s anger for healthcare costs, but the true culprits are more elusive.

Finding the Nerve

A patient with CN VII damage can’t get her lid to cover her cornea in one eye.

Living in a Purple State

A patient with a compromised immune system has a strange visual presentation. Can her peripheral retina explain why?

Out of Rhythm

While amiodarone is highly effective, long-term use is associated with concerning ocular side effects.

Pigmentary Glaucoma, Revisited

New pharmaceutical options may help manage secondary disease.

Protect Your PK Patients

Scleral lenses can improve vision for these eyes if the right precautions are taken.

Screening Measures

A meta-analysis challenges the belief that digital devices turbocharge myopia. But that doesn’t let kids off the hook.

Spring—and Pollen—is in the Air

Are you ready for ocular allergy season? New testing could make it a breeze.

The Rebate Racket

Whoever thought asking patients to mail in proof-of-purchase to get money back on their contact lenses was a good idea?

With Disc Edemas, Act Fast

Treatment is dependent upon the cause of the issue. It’s on you to identify it.

E-Newsletters

Practice Pearls

Expert clinician Paul Karpecki, OD, provides practical insights and management strategies for a wide array of ocular conditions.

OCCRS E-Newsletter

A quarterly e-newsletter by Optometric Cornea, Cataract and Refractive Society (OCCRS) covering the latest information on cornea, cataract and refractive surgery, comanagement and leading technologies.

Optometric Retina Society E-Newsletter

Keep up to date on the latest research and clinical findings in retinal disease care with this quarterly publication from the ORS.

Optometric Physician E-Journal

A weekly e-journal edited by Art Epstein, OD, featuring incisive commentary, timely research summaries and late-breaking news.

Continuing Education

March 2020 • 2.00 Credits

The Do's & Dont's of Oral Medication

January 2020 • 2.00 Credits

Dry Eye Epidemiology in Practice

November 2019 • 2.00 Credits

Overcoming Secondary Glaucomas

Jobs

Jobs Powered By Local Eye Site

Review of Cornea & Contact Lenses

March/April 2020

Women in Optometry

Women In Optometry - November 2019